Levodopa effect on spontaneous speech in Parkinson's disease
Parkinson's disease (PD) is associated with verb deficits detected with tasks including picture naming and verbal fluency. However, these deficits are not frequently reported by the patients themselves. Levodopa, the gold standard for motor symptoms in PD, has been previously implicated to impr...
Gespeichert in:
Veröffentlicht in: | Journal of neurolinguistics 2019-08, Vol.51, p.194-198 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 198 |
---|---|
container_issue | |
container_start_page | 194 |
container_title | Journal of neurolinguistics |
container_volume | 51 |
creator | Bayram, Ece Aslanbaba, Eda Akbostanci, Muhittin Cenk |
description | Parkinson's disease (PD) is associated with verb deficits detected with tasks including picture naming and verbal fluency. However, these deficits are not frequently reported by the patients themselves. Levodopa, the gold standard for motor symptoms in PD, has been previously implicated to improve these verb deficits. We evaluated the effect of levodopa by using a spontaneous speech task which is more naturalistic than the previously used tasks to detect verb deficits. Thirty PD patients, and 30 age-, gender-, years of education-matched healthy controls were included. Patients were tested while motor ‘on’ and ‘off’. Levodopa did not affect spontaneous speech, although it improved the motor symptoms. Compared to controls, PD patients produced shorter and a lower number of sentences. The verb deficit was independent of cognitive or motor performance. The pathophysiology of motor symptoms and verb deficits most likely differ, and levodopa does not improve verb deficits during spontaneous speech.
•Parkinson's patients produce shorter descriptions during spontaneous speech.•Levodopa does not improve spontaneous speech in Parkinson's disease.•Verb deficit in Parkinson's is not directly associated with motor symptoms. |
doi_str_mv | 10.1016/j.jneuroling.2019.03.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2269383573</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0911604419300181</els_id><sourcerecordid>2269383573</sourcerecordid><originalsourceid>FETCH-LOGICAL-c317t-38b00bd728baa12a355625b58cd458b0b644ed3d1f2e308d4019658fa5d698f13</originalsourceid><addsrcrecordid>eNqFkE9LxDAQxYMouK5-h4IHT62TpGlT8KKL_2BBD3oOaTPV1DWpSbvgtzfLCh49zcC894b3IySjUFCg1eVQDA7n4DfWvRUMaFMALwDoAVlQWfNcgmCHZAENpXkFZXlMTmIcAEBIKhbkao1bb_yoM-x77KbMuyyO3k3aoZ9j2hG798y67FmHD-uidxcxMzaijnhKjnq9iXj2O5fk9e72ZfWQr5_uH1fX67zjtJ5yLluA1tRMtlpTprkQFROtkJ0pRbq1VVmi4Yb2DDlIU6YWlZC9FqZqZE_5kpzvc8fgv2aMkxr8HFx6qRirGi65qHlSyb2qCz7GgL0ag_3U4VtRUDtWalB_rNSOlQKuEqtkvdlbMbXYWgwqdhZdh8aGBEUZb_8P-QGIzHcG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2269383573</pqid></control><display><type>article</type><title>Levodopa effect on spontaneous speech in Parkinson's disease</title><source>Elsevier ScienceDirect Journals</source><creator>Bayram, Ece ; Aslanbaba, Eda ; Akbostanci, Muhittin Cenk</creator><creatorcontrib>Bayram, Ece ; Aslanbaba, Eda ; Akbostanci, Muhittin Cenk</creatorcontrib><description>Parkinson's disease (PD) is associated with verb deficits detected with tasks including picture naming and verbal fluency. However, these deficits are not frequently reported by the patients themselves. Levodopa, the gold standard for motor symptoms in PD, has been previously implicated to improve these verb deficits. We evaluated the effect of levodopa by using a spontaneous speech task which is more naturalistic than the previously used tasks to detect verb deficits. Thirty PD patients, and 30 age-, gender-, years of education-matched healthy controls were included. Patients were tested while motor ‘on’ and ‘off’. Levodopa did not affect spontaneous speech, although it improved the motor symptoms. Compared to controls, PD patients produced shorter and a lower number of sentences. The verb deficit was independent of cognitive or motor performance. The pathophysiology of motor symptoms and verb deficits most likely differ, and levodopa does not improve verb deficits during spontaneous speech.
•Parkinson's patients produce shorter descriptions during spontaneous speech.•Levodopa does not improve spontaneous speech in Parkinson's disease.•Verb deficit in Parkinson's is not directly associated with motor symptoms.</description><identifier>ISSN: 0911-6044</identifier><identifier>EISSN: 1873-8052</identifier><identifier>DOI: 10.1016/j.jneuroling.2019.03.001</identifier><language>eng</language><publisher>Tokyo: Elsevier Ltd</publisher><subject>Cognitive ability ; Drug effects ; Fluency ; Levodopa ; Motor task performance ; Movement disorders ; Naming ; Neurodegenerative diseases ; Noun ; Parkinson's disease ; Patients ; Speech ; Spontaneous speech ; Verb ; Verbs ; Word production</subject><ispartof>Journal of neurolinguistics, 2019-08, Vol.51, p.194-198</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright Elsevier Science Ltd. Aug 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c317t-38b00bd728baa12a355625b58cd458b0b644ed3d1f2e308d4019658fa5d698f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0911604419300181$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Bayram, Ece</creatorcontrib><creatorcontrib>Aslanbaba, Eda</creatorcontrib><creatorcontrib>Akbostanci, Muhittin Cenk</creatorcontrib><title>Levodopa effect on spontaneous speech in Parkinson's disease</title><title>Journal of neurolinguistics</title><description>Parkinson's disease (PD) is associated with verb deficits detected with tasks including picture naming and verbal fluency. However, these deficits are not frequently reported by the patients themselves. Levodopa, the gold standard for motor symptoms in PD, has been previously implicated to improve these verb deficits. We evaluated the effect of levodopa by using a spontaneous speech task which is more naturalistic than the previously used tasks to detect verb deficits. Thirty PD patients, and 30 age-, gender-, years of education-matched healthy controls were included. Patients were tested while motor ‘on’ and ‘off’. Levodopa did not affect spontaneous speech, although it improved the motor symptoms. Compared to controls, PD patients produced shorter and a lower number of sentences. The verb deficit was independent of cognitive or motor performance. The pathophysiology of motor symptoms and verb deficits most likely differ, and levodopa does not improve verb deficits during spontaneous speech.
•Parkinson's patients produce shorter descriptions during spontaneous speech.•Levodopa does not improve spontaneous speech in Parkinson's disease.•Verb deficit in Parkinson's is not directly associated with motor symptoms.</description><subject>Cognitive ability</subject><subject>Drug effects</subject><subject>Fluency</subject><subject>Levodopa</subject><subject>Motor task performance</subject><subject>Movement disorders</subject><subject>Naming</subject><subject>Neurodegenerative diseases</subject><subject>Noun</subject><subject>Parkinson's disease</subject><subject>Patients</subject><subject>Speech</subject><subject>Spontaneous speech</subject><subject>Verb</subject><subject>Verbs</subject><subject>Word production</subject><issn>0911-6044</issn><issn>1873-8052</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFkE9LxDAQxYMouK5-h4IHT62TpGlT8KKL_2BBD3oOaTPV1DWpSbvgtzfLCh49zcC894b3IySjUFCg1eVQDA7n4DfWvRUMaFMALwDoAVlQWfNcgmCHZAENpXkFZXlMTmIcAEBIKhbkao1bb_yoM-x77KbMuyyO3k3aoZ9j2hG798y67FmHD-uidxcxMzaijnhKjnq9iXj2O5fk9e72ZfWQr5_uH1fX67zjtJ5yLluA1tRMtlpTprkQFROtkJ0pRbq1VVmi4Yb2DDlIU6YWlZC9FqZqZE_5kpzvc8fgv2aMkxr8HFx6qRirGi65qHlSyb2qCz7GgL0ag_3U4VtRUDtWalB_rNSOlQKuEqtkvdlbMbXYWgwqdhZdh8aGBEUZb_8P-QGIzHcG</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>Bayram, Ece</creator><creator>Aslanbaba, Eda</creator><creator>Akbostanci, Muhittin Cenk</creator><general>Elsevier Ltd</general><general>Elsevier Science Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T9</scope><scope>7TK</scope></search><sort><creationdate>20190801</creationdate><title>Levodopa effect on spontaneous speech in Parkinson's disease</title><author>Bayram, Ece ; Aslanbaba, Eda ; Akbostanci, Muhittin Cenk</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c317t-38b00bd728baa12a355625b58cd458b0b644ed3d1f2e308d4019658fa5d698f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Cognitive ability</topic><topic>Drug effects</topic><topic>Fluency</topic><topic>Levodopa</topic><topic>Motor task performance</topic><topic>Movement disorders</topic><topic>Naming</topic><topic>Neurodegenerative diseases</topic><topic>Noun</topic><topic>Parkinson's disease</topic><topic>Patients</topic><topic>Speech</topic><topic>Spontaneous speech</topic><topic>Verb</topic><topic>Verbs</topic><topic>Word production</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bayram, Ece</creatorcontrib><creatorcontrib>Aslanbaba, Eda</creatorcontrib><creatorcontrib>Akbostanci, Muhittin Cenk</creatorcontrib><collection>CrossRef</collection><collection>Linguistics and Language Behavior Abstracts (LLBA)</collection><collection>Neurosciences Abstracts</collection><jtitle>Journal of neurolinguistics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bayram, Ece</au><au>Aslanbaba, Eda</au><au>Akbostanci, Muhittin Cenk</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Levodopa effect on spontaneous speech in Parkinson's disease</atitle><jtitle>Journal of neurolinguistics</jtitle><date>2019-08-01</date><risdate>2019</risdate><volume>51</volume><spage>194</spage><epage>198</epage><pages>194-198</pages><issn>0911-6044</issn><eissn>1873-8052</eissn><abstract>Parkinson's disease (PD) is associated with verb deficits detected with tasks including picture naming and verbal fluency. However, these deficits are not frequently reported by the patients themselves. Levodopa, the gold standard for motor symptoms in PD, has been previously implicated to improve these verb deficits. We evaluated the effect of levodopa by using a spontaneous speech task which is more naturalistic than the previously used tasks to detect verb deficits. Thirty PD patients, and 30 age-, gender-, years of education-matched healthy controls were included. Patients were tested while motor ‘on’ and ‘off’. Levodopa did not affect spontaneous speech, although it improved the motor symptoms. Compared to controls, PD patients produced shorter and a lower number of sentences. The verb deficit was independent of cognitive or motor performance. The pathophysiology of motor symptoms and verb deficits most likely differ, and levodopa does not improve verb deficits during spontaneous speech.
•Parkinson's patients produce shorter descriptions during spontaneous speech.•Levodopa does not improve spontaneous speech in Parkinson's disease.•Verb deficit in Parkinson's is not directly associated with motor symptoms.</abstract><cop>Tokyo</cop><pub>Elsevier Ltd</pub><doi>10.1016/j.jneuroling.2019.03.001</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0911-6044 |
ispartof | Journal of neurolinguistics, 2019-08, Vol.51, p.194-198 |
issn | 0911-6044 1873-8052 |
language | eng |
recordid | cdi_proquest_journals_2269383573 |
source | Elsevier ScienceDirect Journals |
subjects | Cognitive ability Drug effects Fluency Levodopa Motor task performance Movement disorders Naming Neurodegenerative diseases Noun Parkinson's disease Patients Speech Spontaneous speech Verb Verbs Word production |
title | Levodopa effect on spontaneous speech in Parkinson's disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T16%3A56%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Levodopa%20effect%20on%20spontaneous%20speech%20in%20Parkinson's%20disease&rft.jtitle=Journal%20of%20neurolinguistics&rft.au=Bayram,%20Ece&rft.date=2019-08-01&rft.volume=51&rft.spage=194&rft.epage=198&rft.pages=194-198&rft.issn=0911-6044&rft.eissn=1873-8052&rft_id=info:doi/10.1016/j.jneuroling.2019.03.001&rft_dat=%3Cproquest_cross%3E2269383573%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2269383573&rft_id=info:pmid/&rft_els_id=S0911604419300181&rfr_iscdi=true |